The groundbreaking therapy of the medication represents a major development in the management of the condition. Unlike existing medications, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide602328.theideasblog.com/42580944/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment